Conmed (CNMD) EBIT (2016 - 2020)
Historic EBIT for Conmed (CNMD) over the last 11 years, with Q4 2020 value amounting to $135.5 million.
- Conmed's EBIT fell 455.08% to $135.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $460.3 million, marking a year-over-year decrease of 1227.6%. This contributed to the annual value of $102.6 million for FY2025, which is 4877.25% down from last year.
- As of Q4 2020, Conmed's EBIT stood at $135.5 million, which was down 455.08% from $133.7 million recorded in Q3 2020.
- In the past 5 years, Conmed's EBIT ranged from a high of $142.0 million in Q4 2019 and a low of $71.9 million during Q2 2020
- Moreover, its 5-year median value for EBIT was $113.4 million (2018), whereas its average is $114.7 million.
- In the last 5 years, Conmed's EBIT skyrocketed by 1761.23% in 2019 and then plummeted by 4517.19% in 2020.
- Quarter analysis of 5 years shows Conmed's EBIT stood at $107.0 million in 2016, then increased by 15.89% to $124.0 million in 2017, then grew by 7.02% to $132.7 million in 2018, then grew by 7.03% to $142.0 million in 2019, then decreased by 4.55% to $135.5 million in 2020.
- Its last three reported values are $135.5 million in Q4 2020, $133.7 million for Q3 2020, and $71.9 million during Q2 2020.